"Mount Sinai Gets $12.5M to Study How Hormones Affect Obesity, Osteoporosis"
Researchers from the Icahn School of Medicine at Mount Sinai will use a $12.5 million grant from the National Institutes of Health to study the role of hormones in obesity and osteoporosis. They'll do so through a five-year program of four projects in aging biology, Mount Sinai said Wednesday. The goal of the program is to establish a hormone that's important to the reproductive system, known as follicle-stimulating hormone, or FSH, as a potential therapeutic target. The funding is expected to bring the team closer to creating a therapy with an FSH-blocking antibody to prevent and treat the conditions, said Dr. Mone Zaidi, professor of medicine at Icahn and director of the Mount Sinai Bone Program. Zaidi said he hopes the program will move toward a phase 1 clinical trial at the end of two years.
— Mone Zaidi, MD, PhD, Director, Mount Sinai Bone Program, Professor, Medicine, Endocrinology, Diabetes and Bone Disease, Pharmacological Sciences, Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai